Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 20/20 | 0.77 |
| ▸ | MMP13 | P45452 | 19/20 | 0.69 |
| ▸ | MMP2 | P08253 | 1/20 | 0.69 |
| ▸ | MMP3 | P08254 | 1/20 | 0.69 |
| ▸ | MMP9 | P14780 | 1/20 | 0.69 |
| ▸ | MMP8 | P22894 | 1/20 | 0.69 |
| ▸ | MMP12 | P39900 | 1/20 | 0.69 |
| ▸ | MMP14 | P50281 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26434 | 0.89 | MMP1 (0.83) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL26986 | 0.88 | MMP1 (1.00) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL25130 | 0.86 | MMP1 (0.96) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL6813051 | 0.85 | MMP1 (0.94) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL25304 | 0.83 | MMP1 (1.00) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL6873149 | 0.82 | MMP1 (0.70) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7352297 | 0.81 | MMP1 (0.68) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL6699509 | 0.81 | MMP1 (0.84) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL5413107 | 0.80 | MMP1 (0.68) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL3987272 | 0.80 | MMP1 (0.68) | MMP1MMP13MMP2MMP3MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233829-B1 | PYRIMIDINE AND TRIAZINE DERIVATIVES AND THEIR USE AS AXL INHIBITORS | PFIZER (US) | 2019-08-14 | — | — | EP | disclosed |
| EP-3233829-A1 | PYRIMIDINE AND TRIAZINE DERIVATIVES AND THEIR USE AS AXL INHIBITORS | Pfizer Inc (US) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016097918-A1 | PYRIMIDINE AND TRIAZINE DERIVATIVES AND THEIR USE AS AXL INHIBITORS | PFIZER INC. (US) | 2016-06-23 | — | — | WO | disclosed |